PMDD: when premenstrual mood is more than PMS

Premenstrual dysphoric disorder (PMDD) is a recognised condition in which severe mood and physical symptoms appear in the week or two before a period and then lift soon after bleeding starts. It is not "bad PMS" or a character flaw: it is a cyclical disorder, listed in the DSM-5 and recognised by the NHS, that the leading evidence links to an abnormal brain sensitivity to normal hormone changes, not to abnormal hormone levels. It affects roughly 1 in 20 people who menstruate, can be genuinely disabling, and responds to treatment. If your premenstrual mood feels far beyond ordinary, tracking your symptoms across two cycles and taking that record to a GP is the single most useful first step.

What PMDD actually is

Premenstrual dysphoric disorder is a cyclical mood disorder tied to the menstrual cycle. In 2013 it was moved into the main body of the American Psychiatric Association's DSM-5 as a depressive disorder in its own right, having previously sat in an appendix for further study.² That shift signalled that the evidence had matured, and that the distress people described was real, measurable and treatable.

The symptoms span mood and body. On the emotional side they include marked irritability or anger, a depressed or hopeless mood, anxiety, and sharp mood swings, alongside loss of interest, poor concentration, low energy, and feeling overwhelmed or out of control. Physical symptoms overlap with ordinary premenstrual experience: breast tenderness, bloating, joint or muscle aches, food cravings, and changes in sleep.² What sets PMDD apart is the severity of the mood component and how much it disrupts work, relationships and daily life.

How it differs from PMS (and from PME)

Most people who menstruate notice some premenstrual changes, and mild to moderate PMS is extremely common. The difference with PMDD is degree and disruption. PMS might mean feeling more irritable, tired or bloated for a few days; PMDD means symptoms severe enough to derail functioning, with the mood disturbance front and centre. PMDD also requires a defined cluster of symptoms causing clinically significant distress or impairment, confirmed prospectively, whereas PMS has no single agreed checklist.²

There is a second, frequently missed distinction. Premenstrual exacerbation (PME) is not PMDD. PME describes an existing condition, such as depression, anxiety, bipolar disorder or migraine, that worsens in the luteal phase but does not fully clear after the period. The tell is the follicular phase: in PMDD there is a genuinely symptom-free or near symptom-free window after bleeding, whereas in PME symptoms ease but never reach a clean baseline.² This matters because treatments differ, and the only reliable way to tell them apart is to track symptoms across the whole cycle.

Why timing and tracking confirm it

There is no blood test or scan for PMDD. The diagnosis rests on the pattern: symptoms that reliably appear in the luteal phase, the part of the cycle after ovulation, and then lift within a few days of menstruation starting. Because memory is unreliable and we tend to read the present mood back into the past, a retrospective account is not enough. The DSM-5 specifically requires symptoms to be confirmed by prospective daily ratings over at least two symptomatic cycles before the diagnosis is made.²

The standard tool for this is the Daily Record of Severity of Problems (DRSP), a validated questionnaire on which you rate the relevant symptoms each day. It was tested for reliability and validity by Endicott and colleagues and is used in both clinics and research; the patient charity IAPMD provides it free.⁶ Two cycles of charting show whether your symptoms really are confined to the luteal phase (pointing to PMDD) or persist all month (pointing to PME or another condition), and they give your GP something concrete to act on rather than a description of your worst week.

The leading mechanism: sensitivity, not imbalance

A common and understandable assumption is that PMDD must be caused by "too much" or "too little" of a hormone. The evidence points elsewhere. Studies consistently find that people with PMDD have normal levels of oestrogen and progesterone; what differs is how their brain responds to the ordinary rise and fall of those hormones across the cycle.⁷

The clearest demonstration came from Peter Schmidt, David Rubinow and colleagues at the US National Institute of Mental Health. They used a drug (leuprolide) to switch off ovarian hormone production, which relieved symptoms, and then added back oestrogen or progesterone in a blinded design. Adding the hormones back triggered symptoms in the women with a history of PMS, but not in those without it, even though both groups received the same hormones. The authors concluded that in susceptible people, symptoms represent an abnormal response to normal hormonal changes.³

The most developed explanation for that abnormal response centres on allopregnanolone, a neuroactive steroid the body makes from progesterone. It acts on the GABA-A receptor, the main brake on brain activity, where it normally has a calming effect similar in kind to alcohol or benzodiazepines. The leading hypothesis, supported by human and laboratory studies, is that people with PMDD have an altered, less adaptable GABA-A receptor response to the shifting allopregnanolone of the luteal phase, so the system that should produce calm instead drives irritability, anxiety and low mood.⁷ This connects to the wider GABA system, and remains a leading model rather than a complete account, best read as mechanistic evidence converging with human data.

Evidence-based options to discuss with a clinician

PMDD is treatable, and there is a real menu of options. The right choice depends on your symptoms, your contraceptive needs and your medical history, and is a conversation to have with a GP or specialist rather than something to self-treat. The broad approaches below are the ones with the best supporting evidence.

SSRIs, including luteal-phase dosing

Selective serotonin reuptake inhibitors are the best-evidenced medication for PMDD. A Cochrane review of randomised trials found SSRIs reduce premenstrual symptoms substantially more than placebo, with higher doses generally more effective than low doses.⁵ What is distinctive in PMDD is that they can work quickly and can be taken only in the luteal phase (typically from ovulation or symptom onset until the period starts), not just every day. A 2023 systematic review and meta-analysis by Reilly and colleagues found intermittent, luteal-phase dosing effective and broadly comparable to continuous dosing on symptom change.⁸ Some evidence suggests continuous use may have a modest edge for certain people, so the regimen is worth tailoring with a clinician.

Certain combined oral contraceptives

A specific combined pill containing drospirenone with a low dose of ethinylestradiol, taken on a 24/4 regimen (24 active pills, 4 inactive) is licensed in some settings for PMDD and has the strongest contraceptive-based evidence. A 2023 Cochrane review concluded these pills may improve premenstrual symptoms and the impairment they cause, though it rated the certainty of the evidence as low to moderate.⁹ UK guidance from the Royal College of Obstetricians and Gynaecologists treats combined hormonal contraception, used continuously rather than cyclically, as a reasonable option, since suppressing the cycle can reduce symptoms in some people.¹⁰

Psychological therapy and lifestyle

Cognitive behavioural therapy (CBT) has useful evidence in PMDD. In a randomised trial by Hunter and colleagues comparing CBT, fluoxetine and the two combined, all three improved symptoms; the SSRI worked faster, but CBT was associated with better maintenance of benefit at follow-up, and combining them added little.¹¹ That makes CBT a genuine option, particularly for people who prefer not to take medication or want durable coping strategies. Lifestyle measures (regular exercise, sleep, reducing alcohol, stress management) are recommended by the NHS as sensible first steps, though they are rarely sufficient alone at the more severe end.⁴ If you are weighing up several approaches at once, our guide to building a strategy explains how to change one thing at a time so you can tell what is working.

For the few whose symptoms do not respond to these, specialists may consider GnRH analogues with hormone add-back, which the RCOG reserves for severe, treatment-resistant cases because of effects on bone density.¹⁰ That is firmly specialist territory.

Getting a diagnosis in the UK

The practical route in the UK starts with your GP. Before the appointment, keep a daily symptom diary for at least two menstrual cycles, ideally using the DRSP, noting both how you feel and where you are in your cycle. The NHS itself suggests bringing a diary covering at least two cycles to your appointment.⁴ That record turns a hard-to-describe experience into evidence, and it is what the diagnostic criteria require.

Your GP can discuss the options above and, where needed, refer you on, for example to a gynaecologist with an interest in premenstrual disorders, or to mental health services. The charity Mind and the International Association for Premenstrual Disorders (IAPMD) both provide clear, UK-relevant information and peer support while you wait for or prepare for an appointment.¹² For a structured way to think through your symptoms and questions first, our getting-started guide and the wider insights library are good starting points.

When to get help sooner

PMDD is common and treatable, and effective help exists, but the mood symptoms can be severe, and for some people they include feeling hopeless or having thoughts of suicide. You do not need to wait for a "bad enough" week to ask for support. If you are struggling, please reach out.

This article is educational and does not constitute medical advice, diagnosis, or a treatment recommendation. Medication uses described as “off-label” are not licensed for that purpose in the UK and should only be considered under qualified clinical supervision. Always speak to your GP, pharmacist, or a registered specialist before starting, stopping, or changing any treatment. If you have severe or alarm symptoms - unintentional weight loss, blood in your stool, difficulty swallowing, persistent vomiting, a fever, or severe pain - seek urgent medical care.